MR-Guided Cryoablation of Prostate Bed Recurrences

Overview

About this study

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa
Surgery is not a desirable alternative therapy at the time of enrollment
Radiation therapy has failed or not indicated or can be safely postponed
Tumor size is < 5 cm at its largest diameter
Tumor does not encompass the rectal wall or external urethral sphincter
Performance status is ECOG 2 or better in adults
Patient is able to undergo MRI

Exclusion Criteria:

Patients with pacemaker or defibrillator

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator David Woodrum, M.D., Ph.D.	Open for enrollment	Contact information: Debra Berg (507) 255-8454 rstinterventionaloncology@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Woodrum, M.D., Ph.D.

Open for enrollment

Contact information:

Debra Berg

(507) 255-8454

rstinterventionaloncology@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials